Record Short Videos To Assess Parkinson’s Disease, Nervtex’s First-in-class Ai-based Movement Dysfunction Assessment Software Medical Device Approved

NERVTEX’s MoDAS system, an AI/ML-based Software as a Medical Device (SaMD) for the analysis of motor symptoms of Parkinson’s disease and other movement disorders, has been approved by the China National Medical Products Administration, making it the first video-based AI-powered medical device for the assessment of movement disorders. MoDAS uses consumer-level smart mobile devices to capture video of the patient’s movement status and provides doctors with objective and quantitative information for clinical decision support, greatly improving the evaluation and treatment efficiency of movement disorders such as Parkinson’s disease.